Related Experiment Video

Updated: Aug 21, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[How many patients need treatment for hypercholesterolemia?]

C Serna Arnáiz1, L Montull Navarro, A Vázquez Torguet

  • 1Hospital Arnau de Vilanova, Lleida.

Atencion Primaria
|June 17, 2000
PubMed

Insights

Different guidelines show varying percentages of individuals needing pharmacologic treatment for hypercholesterolemia. Calculating cardiovascular risk using the Framingham equation is crucial for targeted lipid-lowering medication and better population protection.

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacology

Context:

  • Hypercholesterolemia prevalence and treatment needs vary significantly across populations.
  • Current guidelines for pharmacologic intervention in hypercholesterolemia differ in their criteria.
  • Assessing cardiovascular risk is essential for guiding treatment decisions.

Purpose:

  • To determine the proportion of a population requiring pharmacologic treatment for hypercholesterolemia based on diverse guidelines.
  • To compare the treatment recommendations of the US National Cholesterol Education Program (NCEP), The European Society of Atherosclerosis, and The Spanish Society of Atherosclerosis.
  • To evaluate the utility of the Framingham risk score in identifying individuals who would benefit from lipid-lowering medication.

Summary:

  • A descriptive transversal study in Lleida, Spain, analyzed 401 individuals to assess hypercholesterolemia treatment needs.
  • Prevalence of cholesterolemia > 250 mg/dl was 16.3% in men and 22.4% in women.
  • Treatment recommendations varied: NCEP suggested treatment for 20.5% of men and 17.6% of women (aged >6), while the Framingham equation identified 13.7% (23.9% men, 3.5% women) with >20% 10-year cardiovascular risk (aged 30-75).

Impact:

  • Highlights the variability in hypercholesterolemia treatment recommendations based on different guidelines.
  • Emphasizes the importance of using the Framingham cardiovascular risk equation for precise identification of individuals needing lipid-lowering therapy.
  • Supports a more targeted approach to pharmacologic treatment, enhancing protection for high-risk populations against cardiovascular disease.
Abstract

More Related Videos

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...